Showing results (61-70 of 93) with videos related to

Sort By:
Pageof 10
Data in Brief|June 25, 2021
Real-world progression-free survival in first-line advanced non-small cell lung cancer treated with immunotherapy-based regimens using a US datasetDavid Waterhouse, Jenny Lam, Keith A Betts, et al.
American Journal of Alzheimer'S Disease and Other Dementias|May 13, 2026
Community-Based Physician Attitudes Related to the Diagnosis and Treatment of Early Alzheimer's Disease in the United StatesTimothy R Juday, Ashley Holub, Soeren Mattke, et al.
Patient Preference and Adherence|July 28, 2026
Attributes and Trade-Offs Impacting Contraceptive Choice: A Discrete Choice ExperimentVanessa Perez Patel, Ashley Holub, Keith A Betts, et al.
Advances in Therapy|October 8, 2021
Determinants of Hyperkalemia Progression Among Patients with Mild HyperkalemiaRubeen Israni, Keith A Betts, Fan Mu, et al.
International Journal of Chronic Obstructive Pulmonary Disease|February 9, 2017
Comparative efficacy of long-acting β2-agonists as monotherapy for chronic obstructive pulmonary disease: a network meta-analysisJames F Donohue, Keith A Betts, Ella Xiaoyan Du, et al.
Expert Review of Pharmacoeconomics & Outcomes Research|December 28, 2022
Impact on hospitalizations of long-term versus short-term therapy with sodium zirconium cyclosilicate during routine outpatient care of patients with hyperkalemia: the recognize I studyCharles V Pollack, Abiy Agiro, Fan Mu, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|September 23, 2023
Comparative Efficacy of Venetoclax-Based Combination Therapies and Other Therapies in Treatment-Naive Patients With Acute Myeloid Leukemia Ineligible for Intensive Chemotherapy: A Network Meta-AnalysisXue Li, Hae Sun Suh, Jean Lachaine, et al.
Journal of the American Academy of Dermatology|February 25, 2021
Comparative safety and benefit-risk profile of biologics and oral treatment for moderate-to-severe plaque psoriasis: A network meta-analysis of clinical trial dataNeil H Shear, Keith A Betts, Ahmed M Soliman, et al.
The Journal of Allergy and Clinical Immunology. in Practice|May 5, 2023
Real-World Effectiveness Study of Benralizumab for Severe Eosinophilic Asthma: ZEPHYR 2Donna Carstens, Diego J Maselli, Fan Mu, et al.
Journal of Medical Economics|April 28, 2012
Identifying patient subgroups who benefit most from a treatment: using administrative claims data to uncover treatment heterogeneityM Haim Erder, James E Signorovitch, Juliana Setyawan, et al.
Pageof 10